Angel Cid-Arregui

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 4

Top Topics

Helicobacter Pylori Infection

Top Venues

Journal of medical virology

Cancer gene therapy

Deutsches Krebsforschungszentrum

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Deutsches Krebsforschungszentrum

Germany

Group leader :: Targeted Tumor Vaccines

Publications

Isaac Quiros-Fernandez, Sofia Libório-Ramos, Lena Leifert, Bruno Schönfelder, Israel Vlodavsky, Angel Cid-Arregui
Dual T cell receptor/chimeric antigen receptor engineered NK-92 cells targeting the HPV16 E6 oncoprotein and the tumor-associated antigen L1CAM exhibit enhanced cytotoxicity and specificity against tumor cells. Journal of medical virology 96 (5) (2024)
Isaac Quiros-Fernandez, Sofia Libório-Ramos, Lena Leifert, Bruno Schönfelder, Israel Vlodavsky, Angel Cid-Arregui
Dual T cell receptor/chimeric antigen receptor engineered NK-92 cells targeting the HPV16 E6 oncoprotein and the tumor-associated antigen L1CAM exhibit enhanced cytotoxicity and specificity against tumor cells. Journal of medical virology 96 (5) (2024)
Mansour Poorebrahim, Niloufar Mohammadkhani, Reza Mahmoudi, Monireh Gholizadeh, Elham Fakhr, Angel Cid-Arregui
TCR-like CARs and TCR-CARs targeting neoepitopes: an emerging potential. Cancer gene therapy 28 (6) (2021)
Elham Fakhr, Živa Modic, Angel Cid-Arregui
Recent developments in immunotherapy of cancers caused by human papillomaviruses. Immunology 163 (1) (2020)